Cytocom Inc. sell Midas
Start price
18.02.21
/
50%
€9.20
Target price
18.02.22
-
Performance (%)
-68.91%
End price
29.08.21
€2.86
Summary
This prediction ended on 29.08.21 with a price of €2.86. Midas correctly predicted massive losses of -68.91% for Cytocom Inc.. Midas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cytocom Inc. | - | - | - | - |
| iShares Core DAX® | 2.591% | 2.691% | 6.411% | 53.612% |
| iShares Nasdaq 100 | -0.915% | -7.368% | 20.651% | 72.782% |
| iShares Nikkei 225® | 0.145% | -10.196% | 46.169% | 62.432% |
| iShares S&P 500 | -0.367% | -0.833% | 18.019% | 60.744% |
Comments by Midas for this prediction
In the thread Cytocom Inc. diskutieren
Sell Cleveland Biolabs